In this podcast, Mike and Viv break down the elements of the Diabetic Diagnostic and Treatment Protocol. The tools in the protocol work to aid diagnosis, treatment, and monitoring. This podcast outlines where and how each component are used to help you break it down simply for the physician.

In this episode Mike and Viv discuss the importance of follow up in sales. Many accounts come in for labs and other solutions and then the rep is left wondering what happened. Following up closely with the office in the days and weeks post sign up makes all the difference in achieving a successful account.

Lab Director VIctor Castillo joins us to share some best practices to successfully get your clinics on board with molecular PCR testing

Nancy Lavin joins us to discuss a new non-pharmacological alternative for patients experiencing chronic pain. This reduces the practice's liability and creates an additional source of revenue.

Mike and Viv discuss the importance of follow through once you have a doctor enrolled in an ancillary program.

In this podcast, Mike and Viv talk to Alyssa Flores on how she has found her success in this industry. Alyssa shares her pearls of wisdom that have helped her outperform in this competitive and challenging space by working smarter, not harder.

Mike and Viv discuss the important points about MACRA & MIPS that every ancillary rep should know. Understanding how to tie this legislation into the ancillary you are promoting will dramatically increase your sales.

As we reset for the new year, setting sales goals is key to your success. In this episode Mike and Viv discuss how they go about setting goals.

Mike and Viv discuss a survey which asked physicians what are the top things they look for in a medical sales rep.

In this podcast Mike and Viv talk to Drew Hudson about an interesting opportunity for physicians. Drew is producing a documentary on the prevalence of Diabetes across the US and is recruiting doctors to be involved. If you know a practice that has an avid interest in diabetes or onboarding the diabetes protocol then this is a unique opportunity!